Different patients optimize for different things. These are our editor's picks by intent — each backed by the same scoring rubric and honest about price.
The best flat-rate compounded tirzepatide providers hold one price across every dose. Trimi is lowest-priced; NexLife is our pick for bundled flat-rate value.
The cheapest starter price isn't always the cheapest year. Trimi's annual plan (~$125/mo) is the lowest flat rate; MEDVi (~$279) can be the lowest first month but rises with dose.
At higher maintenance doses, flat-rate providers win because the price doesn't climb. NexLife and Trimi hold one price across 2.5–15 mg; dose-tiered providers get expensive.
Some programs bundle lab review into the monthly price; others bill it separately. NexLife includes lab review and coaching; always confirm what's bundled.
Some programs bundle coaching and ongoing support; others charge for it. NexLife includes Care360 coaching; Mochi is built around coaching. Confirm what support is included.
The clearest-priced providers bundle visits, labs and shipping and don't raise the price by dose. NexLife and Trimi advertise inclusive flat pricing; verify cancellation terms.
Compounded tirzepatide is cash-pay (often HSA/FSA-eligible). Trimi is lowest-cost; NexLife is best value. Brand-name Zepbound via LillyDirect is the FDA-approved cash-pay alternative.
At a long-term maintenance dose, predictable flat-rate pricing wins. NexLife holds one price across doses; Trimi is the lowest-cost flat option. Dose-tiered plans cost most at maintenance.